Back to Results
First PageMeta Content
BioMérieux / Encephalitis / Mérieux family / Infectious disease / Bacterial meningitis / Health / Medicine / Meningitis


BioFire Submits De Novo Application to FDA for FilmArray® Meningitis/Encephalitis Panel Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced tha
Add to Reading List

Document Date: 2015-04-14 17:12:02

Open Document

File Size: 234,51 KB

Share Result on Facebook

Company

NYSE Euronext / BioFire Diagnostics LLC / bioMérieux Corporate / /

Country

France / United States / /

Currency

EUR / /

/

Event

Company Listing Change / FDA Phase / Reorganization / /

IndustryTerm

pharmaceutical and cosmetic products / large network / agri-food / diagnostic solutions / finance / /

MedicalCondition

cancer / disease / common infectious pathogens / bacterial meningitis / Meningitis/Encephalitis / encephalitis / diseases / central nervous system infections / infectious diseases / meningitis / syndrome / /

Organization

U.S. Food and Drug Administration / FDA / /

Person

Randy Rasmussen / Claire Doligez / Marcy l’Etoile / Aurore Sergeant / Isabelle Tongio / Wade Stevenson / Laurence Heilbronn / /

/

Position

leader / representative / Vice President of Molecular Biology and CEO / /

Product

FDA / /

PublishedMedium

Molecular Biology / /

Technology

the FilmArray® solution / molecular biology system / in vitro diagnostics / /

URL

http /

SocialTag